Ansa Biotechnologies · Emeryville, CA · Posted 2026-10-29
Ansa Biotechnologies is redefining how scientists access synthetic DNA. Our proprietary enzymatic DNA synthesis platform enables the production of long, complex, sequence-perfect DNA — up to 50 kb clonal products — that traditional chemical synthesis cannot achieve. Backed by over $54M in Series B f…
Apply on the company siteTailor my resume for this jobFree 5-day trial — sign up with your email to apply. Mahatrix Technologies does not charge any percentage of your salary.